SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-451560"
 

Sökning: id:"swepub:oai:DiVA.org:uu-451560" > Interleukin-15 resp...

Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy

Barrenäs, Fredrik (författare)
Uppsala universitet,Beräkningsbiologi och bioinformatik
Hansen, Scott G. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Law, Lynn (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
visa fler...
Driscoll, Connor (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Green, Richard R. (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Smith, Elise (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Chang, Jean (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Golez, Inah (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Urion, Taryn (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Peng, Xinxia (författare)
North Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC USA.
Whitmore, Leanne (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Newhouse, Daniel (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
Hughes, Colette M. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Morrow, David (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Randall, Kurt T. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Selseth, Andrea N. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Ford, Julia C. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Gilbride, Roxanne M. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Randall, Bryan E. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Ainslie, Emily (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Oswald, Kelli (författare)
North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA.
Shoemaker, Rebecca (författare)
North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA.
Fast, Randy (författare)
North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA.
Bosche, William J. (författare)
North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA.
Axthelm, Michael K. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Fukazawa, Yoshinori (författare)
Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Pavlakis, George N. (författare)
Leidos Biomedical Res Inc, Frederick Natl Lab, SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD USA.
Felber, Barbara K. (författare)
Natl Canc Inst Frederick, Human Retrovirus Sect, Vaccine Branch, Frederick, MD USA.
Fourati, Slim (författare)
Natl Canc Inst Frederick, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Frederick, MD USA.
Sekaly, Rafick-Pierre (författare)
Natl Canc Inst Frederick, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Frederick, MD USA.
Lifson, Jeffrey D. (författare)
North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA.
Komorowski, Jan (författare)
Uppsala universitet,Beräkningsbiologi och bioinformatik
Kosmider, Ewelina (författare)
Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.;Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA.
Shao, Danica (författare)
Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.;Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA.
Song, Wenjun (författare)
Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.;Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA.
Edlefsen, Paul T. (författare)
Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.;Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA.
Picker, Louis J. (författare)
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.;Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.
Gale, Michael, Jr. (författare)
Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
visa färre...
 (creator_code:org_t)
2021-07-06
2021
Engelska.
Ingår i: PLoS Pathogens. - : Public Library of Science (PLoS). - 1553-7366 .- 1553-7374. ; 17:7
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Simian immunodeficiency virus (SIV) challenge of rhesus macaques (RMs) vaccinated with strain 68-1 Rhesus Cytomegalovirus (RhCMV) vectors expressing SIV proteins (RhCMV/SIV) results in a binary outcome: stringent control and subsequent clearance of highly pathogenic SIV in similar to 55% of vaccinated RMs with no protection in the remaining 45%. Although previous work indicates that unconventionally restricted, SIV-specific, effector-memory (EM)-biased CD8(+) T cell responses are necessary for efficacy, the magnitude of these responses does not predict efficacy, and the basis of protection vs. non-protection in 68-1 RhCMV/SIV vector-vaccinated RMs has not been elucidated. Here, we report that 68-1 RhCMV/SIV vector administration strikingly alters the whole blood transcriptome of vaccinated RMs, with the sustained induction of specific immune-related pathways, including immune cell, toll-like receptor (TLR), inflammasome/cell death, and interleukin-15 (IL-15) signaling, significantly correlating with subsequent vaccine efficacy. Treatment of a separate RM cohort with IL-15 confirmed the central involvement of this cytokine in the protection signature, linking the major innate and adaptive immune gene expression networks that correlate with RhCMV/SIV vaccine efficacy. This change-from-baseline IL-15 response signature was also demonstrated to significantly correlate with vaccine efficacy in an independent validation cohort of vaccinated and challenged RMs. The differential IL-15 gene set response to vaccination strongly correlated with the pre-vaccination activity of this pathway, with reduced baseline expression of IL-15 response genes significantly correlating with higher vaccine-induced induction of IL-15 signaling and subsequent vaccine protection, suggesting that a robust de novo vaccine-induced IL-15 signaling response is needed to program vaccine efficacy. Thus, the RhCMV/SIV vaccine imparts a coordinated and persistent induction of innate and adaptive immune pathways featuring IL-15, a known regulator of CD8(+) T cell function, that support the ability of vaccine-elicited unconventionally restricted CD8(+) T cells to mediate protection against SIV challenge.

Ämnesord

NATURVETENSKAP  -- Biologi -- Immunologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Immunology (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy